How to Help Your Patients Find Paragard in Stock: A Provider's Guide

One of the most frustrating situations in reproductive healthcare: a patient is motivated, their insurance covers it, and they're ready for their Paragard insertion — but your clinic ran out of stock last week and the next shipment is two weeks out. What do you do?

This guide gives you a clear workflow to help patients find Paragard near them quickly — protecting continuity of care and reducing the risk that they go without effective contraception.

Step 1: Use medfinder to Search for Paragard Near Your Patient

The fastest way to find a nearby clinic or pharmacy that has Paragard in stock is to use medfinder for providers. The service calls pharmacies and providers near your patient's location to check current availability, then texts results directly to the patient. This takes the search burden off your staff and off the patient.

How to integrate this into your workflow:

When a patient presents for an IUD consultation and you don't have Paragard in stock, hand them a card with the medfinder.com URL

Instruct them to enter 'Paragard' and their zip code to get a list of nearby providers with stock

Schedule a follow-up to confirm they were able to get the device inserted

Step 2: Refer to Planned Parenthood or Title X Clinics

Planned Parenthood health centers are among the most consistent stockists of Paragard in the country. For most private OB-GYN practices, maintaining a warm referral relationship with your nearest Planned Parenthood or Title X clinic is an essential part of reproductive healthcare continuity.

Key advantages of PP and Title X referral:

Typically shorter appointment wait times (often same-day or next-day)

Sliding-scale fees available for uninsured or underinsured patients

Extensive experience with nulliparous insertions

Medicaid and most major insurance plans accepted

Step 3: Discuss Miudella as a Same-Appointment Copper IUD Alternative

If your practice is considering stocking both copper IUDs, Miudella (FDA-approved February 2025) offers a compelling supplement to your Paragard inventory. It uses a smaller insertion device and contains less copper than Paragard, with clinical data showing a reduction in heavy menstrual bleeding — a common reason patients discontinue copper IUDs.

Clinical considerations when offering Miudella as an alternative:

Current FDA-approved duration is 3 years (8-year data expected); Paragard is 10 years

Both are hormone-free and immediately reversible

Patients who want 10-year protection should still pursue Paragard when available

Miudella is still becoming widely available — verify with your distributor whether it's accessible in your area

Step 4: Prescribe a Bridge Method for Immediate Protection

If the patient needs contraceptive coverage now and their IUD insertion will be delayed, prescribe a bridge method:

Progestin-only pill (POP): Norethindrone 0.35 mg daily. Low systemic hormone exposure; appropriate for those who want to minimize hormones.

Combination oral contraceptive: For patients with no estrogen contraindications.

Barrier method: Male or female condoms; recommend for patients who specifically avoid all hormones.

Step 5: Proactively Manage Your Inventory

Reactive stockouts are avoidable. Here's a practical inventory protocol for practices that insert IUDs:

Set a reorder point (e.g., trigger a new order when stock falls below 3 units)

Coordinate with your distributor for standing monthly orders based on average insertion volume

Train front desk staff to ask 'Is this for a copper IUD insertion?' when booking, and flag for device availability before confirmation

Maintain a waitlist for patients who want Paragard — contact them immediately when stock arrives

Documentation and Informed Consent Considerations

In light of the ongoing MDL, documentation has become more important than ever for Paragard insertions. Ensure your informed consent process explicitly covers:

Risk of perforation (< 1 in 1,000) and expulsion (higher in nulliparous patients)

Risk of device fragmentation during removal (material disclosed in recent litigation)

Alternatives discussed and why patient chose Paragard over hormonal IUDs

For more on the 2026 Paragard availability landscape, see: Paragard Shortage: What Providers and Prescribers Need to Know in 2026.